Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Lab Reports & Analysis Batch-level documentation supports qualified research evaluation
The compounds acylated structure significantly extends its half-life compared to native amylin to approximately 160195 hours making once-weekly research protocols feasible and practical
As of late 2025, over 200 human studiesincluding dozens of randomized controlled trials (RCTs)demonstrate that tPBM is safe, well-tolerated, and remarkably effective across a spectrum of brain disorders that have long defied conventional pharmacology: traumatic brain injury (TBI), stroke, major depressive disorder (MDD), Alzheimers disease (AD), Parkinsons disease (PD), autism spectrum disorder (ASD), post-COVID neurological sequelae, and even complex inflammatory conditions such as chronic Lyme disease and mold-related biotoxin illness.
DSIPs mechanism of action in the CNS appears to warrant intranasal application as a non-invasive means to directly cross the BBB
Pinealon (EDR Tripeptide / Glutamyl-aspartyl-arginine) is a synthetic short-chain peptide bioregulator engineered for central nervous system and neuro-epigenetic research
The following is a sample of the questions most commonly asked: It became clear that the initial financial model was not adequate for answering these questions
